These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23996697)

  • 21. Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma.
    Qiu F; Yang L; Zhang L; Yang X; Yang R; Fang W; Wu D; Chen J; Xie C; Huang D; Zhou Y; Lu J
    Gene; 2015 Jul; 565(2):180-6. PubMed ID: 25861865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility.
    Li S; Lu Z; Yao M; Ning S; Wu Y; Zhou X; Zhong C; Yan K; Xie Y; Wei Z
    Dis Markers; 2017; 2017():6309754. PubMed ID: 28694559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population.
    Xing H; Chen X; Sun H; Han Y; Ding L; Chen X
    Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):221-226. PubMed ID: 31541294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Nasopharyngeal Carcinoma Associated with Single Nucleotide Polymorphisms in the MicroRNA Binding Site of
    Zheng H; Wu L; Wang X; Chen Q
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):508-519. PubMed ID: 32644852
    [No Abstract]   [Full Text] [Related]  

  • 25. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
    Kjersem JB; Ikdahl T; Guren T; Skovlund E; Sorbye H; Hamfjord J; Pfeiffer P; Glimelius B; Kersten C; Solvang H; Tveit KM; Kure EH
    BMC Cancer; 2012 Nov; 12():534. PubMed ID: 23167843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
    Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
    Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
    Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
    Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
    Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms in interleukin 13 gene with the susceptibility to nasopharyngeal carcinoma in a Chinese population.
    Wang R; Qin HM; Liao BY; Yang FL; Wang JL
    Cytokine; 2019 Mar; 115():121-126. PubMed ID: 30472105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma.
    Lung RW; Wang X; Tong JH; Chau SL; Lau KM; Cheng SH; Woo JK; Woo J; Leung PC; Ng MH; Tang NL; To KF
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E28-38. PubMed ID: 22711332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Wang B; Xu J; Zhou R; Zhang Q
    Med Oncol; 2013 Mar; 30(1):470. PubMed ID: 23345117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
    Deng M; Tang H; Zhou Y; Zhou M; Xiong W; Zheng Y; Ye Q; Zeng X; Liao Q; Guo X; Li X; Ma J; Li G
    J Cell Sci; 2011 Sep; 124(Pt 17):2997-3005. PubMed ID: 21878506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of KRAS Gene Expression and LCS6 Variant in Genomic and Cell-Free DNA of Iranian Women With Endometriosis.
    Farahani MS; Shahbazi S; Moghaddam SA; Mahdian R
    Reprod Sci; 2015 Jun; 22(6):679-84. PubMed ID: 25361550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population.
    Patricia Gallegos-Arreola M; Briseño Zuno CJ; Eduardo Figuera L; Zúñiga González GM; Perales Mederos CI; Puebla Pérez AM; Rosales Reynoso MA
    J BUON; 2020; 25(1):176-181. PubMed ID: 32277629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population.
    Xiao M; Hu S; Zhang L; Huang J; Jiang H; Cai X
    Mutagenesis; 2013 Sep; 28(5):577-82. PubMed ID: 23883608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two polymorphisms of CD44 3'UTR weaken the binding of miRNAs and associate with naso-pharyngeal carcinoma in a Chinese population.
    Lou F; Ma HN; Xu L; Chen M; Zhu YB
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2444-52. PubMed ID: 25268088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.
    Wang JL; Nong LG; Tang YJ; Wei YS; Yang FL; Wang CF
    Med Oncol; 2014 Jul; 31(7):20. PubMed ID: 24913806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.
    Saridaki Z; Weidhaas JB; Lenz HJ; Laurent-Puig P; Jacobs B; De Schutter J; De Roock W; Salzman DW; Zhang W; Yang D; Pilati C; Bouché O; Piessevaux H; Tejpar S
    Clin Cancer Res; 2014 Sep; 20(17):4499-4510. PubMed ID: 25183481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.